CELIACARE

Serial Number 90647417
Registration 7367527
700

Registration Progress

Application Filed
Apr 15, 2021
Under Examination
Aug 23, 2022
Approved for Publication
Jun 28, 2022
Published for Opposition
Jun 28, 2022
Registered
Apr 23, 2024

Basic Information

Serial Number
90647417
Registration Number
7367527
Filing Date
April 15, 2021
Registration Date
April 23, 2024
Published for Opposition
June 28, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 23, 2024
Registration
Registered
Classes
005

Rights Holder

NEW DAY DIAGNOSTICS LLC

16
Address
138 NW 16TH STREET
BOCA RATON, FL 33432

Ownership History

New Day Diagnostics LLC

Original Applicant
16
Boca Raton, FL

New Day Diagnostics LLC

Owner at Publication
16
Boca Raton, FL

NEW DAY DIAGNOSTICS LLC

New Owner After Publication #1
16
BOCA RATON, FL

NEW DAY DIAGNOSTICS LLC

Original Registrant
16
BOCA RATON, FL

Legal Representation

Attorney
Stephen P. McNamara

USPTO Deadlines

Next Renewal Deadline
1750 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-23)
Due Date
April 23, 2030
Grace Period Ends
October 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

40 events
Date Code Type Description
Apr 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Mar 21, 2024 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 20, 2024 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 17, 2024 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Mar 17, 2024 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Feb 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 23, 2024 EISU I TEAS STATEMENT OF USE RECEIVED
Feb 23, 2024 EX3G S SOU EXTENSION 3 GRANTED
Feb 23, 2024 EXT3 S SOU EXTENSION 3 FILED
Feb 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 23, 2024 IUAF S USE AMENDMENT FILED
Oct 11, 2023 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 22, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2023 EX2G S SOU EXTENSION 2 GRANTED
Aug 18, 2023 EXT2 S SOU EXTENSION 2 FILED
Aug 18, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Jan 10, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 6, 2023 EX1G S SOU EXTENSION 1 GRANTED
Jan 6, 2023 EXT1 S SOU EXTENSION 1 FILED
Jan 6, 2023 EEXT I SOU TEAS EXTENSION RECEIVED
Aug 23, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jun 28, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2022 PUBO A PUBLISHED FOR OPPOSITION
Jun 8, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2022 ALIE A ASSIGNED TO LIE
May 19, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 19, 2022 XAEC I EXAMINER'S AMENDMENT ENTERED
May 19, 2022 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 19, 2022 GNEA O EXAMINERS AMENDMENT E-MAILED
May 19, 2022 CNEA R EXAMINERS AMENDMENT -WRITTEN
May 17, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
May 16, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
May 16, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 9, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 9, 2021 GNRT F NON-FINAL ACTION E-MAILED
Dec 9, 2021 CNRT R NON-FINAL ACTION WRITTEN
Dec 8, 2021 DOCK D ASSIGNED TO EXAMINER
Jul 22, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 19, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Immunochromatographic test cartridges for clinical testing the presence of antibodies to gluten; medical devices, namely, immunochromatographic test cartridges, for clinical testing for anti-tissue transglutaminase IgA antibodies; celiac disease diagnosis and screening testing kits comprised of disinfectant alcohol wipe to disinfect skin, lancet for skin puncture to cause bleeding to obtain blood sample, blood collection micropipette to obtain blood sample from lancet site, container of dilution buffer to dilute blood sample, and celiac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood sample; gluten sensitivity and intolerance testing kits comprised of disinfectant wipe to disinfect skin, lancet for skin puncture to cause bleeding to obtain blood sample, micropipette to obtain blood sample from lancet site, container of diluent to dilute blood sample, and celiac disease test cartridge for receiving diluted blood sample and provide an immunochromatographic test for anti-tissue transglutaminase IgA antibodies in the diluted blood
First Use Anywhere: Nov 13, 2023
First Use in Commerce: Nov 13, 2023

Additional Information

Pseudo Mark
CELIA CARE

Classification

International Classes
005